You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
#carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

A Better Way to Effective Patient Management

We all know patients don’t get sick on our schedules. They come to us when they need care — 24 hours a day, 365 days a year. Cepheid’s GeneXpert® System was designed with this in mind — to meet the demands of unpredictable test volumes and deliver fast answers for maximum impact on patient care. With nearly 30 available CE-IVD tests, Cepheid is your partner for empowering clinicians with fast, accurate results.

#carousel-content-1 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-1 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VIDEO

Australian Hospital Emergency Department leverages GeneXpert® for rapid flu testing

St Vincent’s Hospital Pathology (Melbourne, Australia) supports Emergency Department by delivering rapid flu testing with Cepheid's GeneXpert® System.

Watch Video

Video Image
VIDEO

Cepheid GeneXpert — A Game Changing Testing Platform

Become an Xpert with our 2 minute video! Learn how bringing products like Xpert® CT/NG* (Chlamydia and Gonorrhea) testing in office can be the game changer you need!

Watch Video

Video Image

Webinars

#carousel-content-3 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-3 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
WEBINAR

Bringing Molecular Testing Closer to the Patient

Over the past 20 years, there has been a continuous shift toward the decentralization of clinical laboratory testing. With recent advances in the speed and accuracy of point-of-care tests, it is now possible to bring molecular infectious disease testing closer to the patient. This webinar explores the benefits of molecular point-of-care testing as a means of improving patient outcomes and quality of care. Currently available testing methods are reviewed, with an emphasis on the importance of lab testing in the era of performance-driven healthcare.

Simplification of testing and treatment in the quest to eliminate hepatitis C infection
WEBINAR

Simplification of testing and treatment in the quest to eliminate hepatitis C infection

Globally, 71 million people are living with hepatitis C virus (HCV) infection, but the burden of HCV continues to increase. Between 2015 and 2030, WHO targets include reducing new HCV infections by 80% and HCV deaths by 65%, and increasing HCV diagnoses from <20% to 90% and the number of eligible persons receiving HCV treatment from <10% to 80%. To achieve these targets, targeted interventions are needed to enhance HCV testing, linkage to care, and treatment (“the HCV care cascade”). This presentation reviews available evidence on strategies that have been successfully used to enhance HCV testing, linkage to care.

Early diagnosis of HIV and use of molecular Point-of-Care HIV testing as part of a comprehensive strategy to end HIV transmission&nbsp;
WEBINAR

Early diagnosis of HIV and use of molecular Point-of-Care HIV testing as part of a comprehensive strategy to end HIV transmission 

According to UNAIDS1 the world is embarking on a Fast-Track strategy to end the AIDS epidemic by 2030. There is a strong global consensus that powerful tools now exist to end the AIDS epidemic. HIV treatment can dramatically extend the lifespan of people living with HIV and effectively prevent HIV transmission. HIV testing is a crucial element, where a positive result offers the opportunity to start treatment as soon as possible and a confirmed negative result opens the possibility to start quickly with Pre-Exposure Prophylaxis (PrEP). On the other side, HIV programs will only be effective if community groups and organisations are part of the implementation. This webinar will explore the benefits of molecular Point-Of-Care HIV testing, within the context of a community centre for men who have sex with men (MSM) and Transgender Women (TW), for three different applications: confirmation of a positive HIV rapid test, detection of an acute HIV infection, and screening of acute infections at the start of PrEP. 1 http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf CE-IVD. In Vitro Diagnostic Medical Device. Not all tests available in all countries. Not available in the U.S.

The Neglected STI: Trichomonas vaginalis
WEBINAR

The Neglected STI: Trichomonas vaginalis

Among US women ages 14-49 the prevalence of Trichomonas vaginalis infection is estimated to be 2.3 million, though 85% of women found to have trichomoniasis report no symptoms. With varied complications such as increased risk of HSV-2/HIV acquisition, pelvic inflammatory disease and pre-term birth it has become increasingly important to identify and treat these patients quickly. This webinar will explore the renewed interest to screen and diagnose T. vaginalis in women. It will examine current testing methods available and provide updates regarding treatment options.

Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine
WEBINAR

Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine

In this webinar, Dr. Larissa May will discuss the diagnosis of sexually transmitted infections in the Emergency Department, the need for evidence-based medicine, and how same-visit treatment and management can be facilitated with on-demand testing for CT/NG.

Key Links

GeneXpert Family of Systems

GeneXpert System technology is the cornerstone of our approach to molecular diagnostics.

Flu & RSV Molecular Test - Xpert Xpress Flu/RSV & Xpert Xpress Flu

Cepheid's on-demand molecular Xpert Xpress Flu/RSV and Xpert Xpress Flu tests provides accurate and reliable detection of Flu A, Flu B, and RSV.

Connect To Better Outcomes

Request Info
Back to Top